Bulletin
Investor Alert

London Markets Open in:

Portage Biotech Inc.

NAS: PRTG

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 29, 2021, 4:47 p.m.

/zigman2/quotes/205701577/composite

$

15.00

Change

0.00 0.00%

Volume

Volume 327

Quotes are delayed by 20 min

/zigman2/quotes/205701577/composite

Previous close

$ 15.61

$ 15.00

Change

-0.61 -3.91%

Day low

Day high

$15.00

$16.68

Open

52 week low

52 week high

$13.00

$44.98

Open

Annual Financials for Portage Biotech Inc.

Fiscal year is April-March. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense -----
Depreciation -----
Amortization of Intangibles -----
Gross Income -----
20172018201920202021 5-year trend
SG&A Expense 35.49M2.23M2.76M5.98M12.44M
Research & Development 32.45M561,000762,0004.11M7.31M
Other SG&A 3.04M1.67M2M1.87M5.13M
Other Operating Expense -----
Unusual Expense ---9,0002.27M
EBIT after Unusual Expense ---(9,000)(14.71M)
Non Operating Income/Expense -126M(691,000)6,000484,000
Non-Operating Interest Income --111,00011,000-
Equity in Affiliates (Pretax) -----
Interest Expense 552,42232,00088,000557,000177,000
Gross Interest Expense 552,42232,00088,000557,000177,000
Interest Capitalized -----
Pretax Income (36.04M)123.74M(3.43M)(6.53M)(14.4M)
Income Tax ---740,0002.3M
Income Tax - Current Domestic ---740,0002.3M
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates 35.4M-(162,000)18,000(490,000)
Other After Tax Income (Expense) -----
Consolidated Net Income (641,274)123.74M(3.59M)(7.25M)(17.19M)
Minority Interest Expense (16.94M)-(959,000)(1.92M)(1.36M)
Net Income 16.3M123.74M(2.64M)(5.33M)(15.83M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 16.3M123.74M(2.64M)(5.33M)(15.83M)
Preferred Dividends -----
Net Income Available to Common 16.3M123.74M(2.64M)(5.33M)(15.83M)
EPS (Basic) 6.0046.00(0.55)(0.49)(1.35)
Basic Shares Outstanding 2.54M2.68M4.82M10.95M11.73M
EPS (Diluted) 6.0046.00(0.55)(0.49)(1.35)
Diluted Shares Outstanding 2.72M2.7M4.82M10.95M11.73M
EBITDA (35.49M)(2.23M)(2.76M)(5.98M)(12.44M)
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.